FilingSEC EDGAR6-K
Scinai Expands CDMO Business with $5.1 Million Agreement
· SEC accepted
StageAgreement Executed
Filing content
Scinai Immunotherapeutics announced a $5.1 million development and clinical manufacturing agreement with a U.S.-listed biopharmaceutical company.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…